eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, MMP↓, Casp3↑, ROS↑, eff↑,
| - |
in-vitro, |
Colon, |
HT29 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
eff↑, Casp3↑, Casp7↑, NF-kB↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Colon, |
SW480 |
|
|
|
- |
in-vitro, |
Colon, |
HT29 |
|
|
|
tumCV↓, Apoptosis↑, P53↑, BAX↑, MDM2↓, Bcl-2↓, Bcl-xL↓, Casp9↑, Casp3↑, cl‑PARP↑, STAT3↓, survivin↓, cycD1/CCND1↓, CycD3↓, ROS↑, eff↓, eff↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
ChemoSen↑, P-gp↓, eff↑,
OS↑, eff↑,
ChemoSen↑, RadioS↑, Ferroptosis↑, eff↑, eff↑, GSH↓, eff↓,
eff↑, TumCD↑, MusCon↓, Temp↓, eff↑, eff↓, eff↑, eff∅, other↑,
| - |
in-vitro, |
Colon, |
COLO205 |
|
|
|
eff↑, ROS↑, tumCV↓, Casp3↑, Bcl-2↓, MMP↓, eff↑,
| - |
in-vitro, |
Lung, |
H157 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
TrxR↓, selectivity↑, eff↑, eff↝, ROS↑, MMP↓, Apoptosis↑, eff↑,
TumVol↓, OS↑, *IL6↓, *NF-kB↓, *eff↑, *Casp3↓, *TNF-α↓, *Catalase↑, *NO↓, *ROS↓, *Inflam↓, *Apoptosis↓,
| - |
in-vitro, |
Colon, |
MC38 |
|
|
|
- |
in-vitro, |
lymphoma, |
L428 |
|
|
|
NF-kB↓, eff↑, eff↓,
| - |
in-vitro, |
Colon, |
SW48 |
|
|
|
- |
in-vitro, |
Colon, |
LoVo |
|
|
|
ERK↓, p‑PKM2↓, GLUT1↓, Warburg↓, TumCD↑, eff↑, ROS↓, cMyc↓,
| - |
in-vitro, |
RCC, |
RCC4 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-435 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
Colon, |
SW48 |
|
|
|
- |
in-vitro, |
GBM, |
U251 |
|
|
|
eff↑, Warburg↓, BioAv↑, ROS↑, DNAdam↑, ATP↓, eff↑, necrosis↑, PARP↑,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GSH↓, 1, ROS↓, 1, ROS↑, 5, TrxR↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 3,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, p‑PKM2↓, 1, Warburg↓, 2,
Cell Death ⓘ
Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 2, Bcl-xL↓, 1, Casp3↑, 4, Casp7↑, 1, Casp9↑, 1, Ferroptosis↑, 1, MDM2↓, 1, necrosis↑, 1, survivin↓, 1, TumCD↑, 2,
Transcription & Epigenetics ⓘ
other↑, 1, tumCV↓, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1, PARP↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, CycD3↓, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, STAT3↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 2,
Cellular Microenvironment ⓘ
Temp↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 2, eff↓, 4, eff↑, 18, eff↝, 1, eff∅, 1, RadioS↑, 1, selectivity↑, 1,
Functional Outcomes ⓘ
MusCon↓, 1, OS↑, 2, TumVol↓, 1,
Total Targets: 47
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, ROS↓, 1,
Cell Death ⓘ
Apoptosis↓, 1, Casp3↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Immune & Inflammatory Signaling ⓘ
IL6↓, 1, Inflam↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Total Targets: 11
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:961 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page